Back to HomeBeta

ICD-10 Coding for B-cell Lymphoma(C83.30, C83.3A)

Complete ICD-10-CM coding and documentation guide for B-cell Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Diffuse Large B-cell LymphomaDLBCL

Related ICD-10 Code Ranges

Complete code families applicable to B-cell Lymphoma

C83.3-C83.39Primary Range

Diffuse large B-cell lymphoma

This range covers the primary codes for diffuse large B-cell lymphoma, including specific sites and remission status.

Other specified types of non-Hodgkin lymphoma

This range includes codes for differentiating other types of non-Hodgkin lymphoma, such as NK/T-cell lymphoma.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C83.30Diffuse large B-cell lymphoma, unspecified siteUse when DLBCL is confirmed but the specific site is not documented.
  • Histologically confirmed DLBCL
  • Absence of MYC/BCL2 rearrangements
C83.3ADiffuse large B-cell lymphoma in remissionUse for patients in remission post-treatment with documented evidence.
  • No evidence of disease on PET-CT
  • Flow cytometry confirms CD19- B-cells

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for B-cell lymphoma

Essential facts and insights about B-cell Lymphoma

The ICD-10 code for diffuse large B-cell lymphoma is C83.30 for unspecified site and C83.3A for remission status.

Primary ICD-10-CM Codes for b-cell lymphoma

Diffuse large B-cell lymphoma, unspecified site
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed DLBCL without specific site documentation.

Applicable To

  • DLBCL not otherwise specified

Excludes

Clinical Validation Requirements

  • Histologically confirmed DLBCL
  • Absence of MYC/BCL2 rearrangements

Code-Specific Risks

  • Risk of using unspecified code when specific site is known.

Coding Notes

  • Ensure specific site is documented if known to avoid unspecified code.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of non-Hodgkin lymphoma

Z85.81
Use for patients with a history of lymphoma impacting current care.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

NK/T-cell lymphoma, unspecified

C85.10
Presence of CD56+ and EBV+ markers.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting B-cell Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C83.30.

Impact

Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.

Mitigation Strategy

Regularly update patient records with remission status., Use standardized templates for documentation.

Impact

Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Always document and code the specific site and status of the lymphoma.

Impact

Inadequate documentation of remission status.

Mitigation Strategy

Ensure all remission claims are supported by clinical evidence.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for B-cell Lymphoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for B-cell Lymphoma

Use these documentation templates to ensure complete and accurate documentation for B-cell Lymphoma. These templates include all required elements for proper coding and billing.

DLBCL Diagnosis and Treatment

Specialty: Oncology

Required Elements

  • Histology
  • Stage
  • Biomarkers
  • Treatment response

Example Documentation

**Histology**: Diffuse large B-cell lymphoma, non-germinal center subtype (CD10-, BCL6-, MUM1+) **Stage**: Ann Arbor IVB (spleen, bone marrow) **Biomarkers**: MYC rearrangement negative (FISH), BCL2 IHC 70% **Treatment Response**: Post-R-CHOP: PET-CT Deauville 2; Bone marrow biopsy: No residual CD20+ cells

Examples: Poor vs. Good Documentation

Poor Documentation Example
DLBCL stable.
Good Documentation Example
Diffuse large B-cell lymphoma, germinal center type, stage IV, MYC rearrangement negative.
Explanation
The good example provides specific histology, stage, and biomarker information.

Need help with ICD-10 coding for B-cell Lymphoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more